MarketInOut Stock Screener Log In | Sign Up

Jagsonpal Pharmaceuticals Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:50
Jagsonpal Pharmaceuticals Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization13,985 mln
Float15.00 mln
Earnings Date10/28/2026

EPS

6.71
Stretched

P / E

33.20
Overvalued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.26
Borderline

Relative Strength

69 / 100
Outperforming

Debt / Equity

0.03
Debt-free

Business Description

Jagsonpal Pharmaceuticals is an India-based drug maker with over four decades of experience, producing and selling a wide range of medicines both domestically and abroad. The company serves several medical fields, including women's health, bone and joint care, skin conditions, and children's health. Its products come in many forms, such as tablets, capsules, injections, and syrups.

Key Fundamentals

EPS6.71
P/E33.20
ROE17.74
RPS43.90
ROIC24.86
ROA15.18
Interest Cover50.60
EBITDA, mln710
EV / EBITDA21.85
EV / EBIT25.12
Revenue, mln2,938
EV / Revenue5.28

Quote Details

Last 222.80
Change -1.2 (-0.54%)
Open 221.20
Volume 1,904
Turnover 424,211
Average Volume 10,452

Financial Ratios

Pre-Tax Profit Margin21
Current Ratio5.06
Price / Book5.75
Price / Tangible Book8.01
Price / Cash Flow56.50
Price / Free Cash Flow28.52
Debt / Equity0.03
Price / Sales5.49
PEG Ratio1.34

Financial Strength

Altman Z-Score24.34
Piotroski F-Score 5 / 9
Beneish M-Score-2.26
Price to Intrinsic Value2.10
Price to Lynch Fair Value1.43
Price to Graham Number3.59
Shiller PE Ratio65.19

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.67% 88 / 100   
1 Month -8.63% 43 / 100   
2 Months 1.62% 72 / 100   
6 Months 13.8% 77 / 100   
1 Year 3.2% 74 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog